146 related articles for article (PubMed ID: 17019374)
1. An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women.
Hirschberg AL; Edlund M; Svane G; Azavedo E; Skoog L; von Schoultz B
Menopause; 2007; 14(1):89-96. PubMed ID: 17019374
[TBL] [Abstract][Full Text] [Related]
2. Digitized assessment of mammographic breast density--effects of continuous combined hormone therapy, tibolone and black cohosh compared to placebo.
Lundström E; Hirschberg AL; Söderqvist G
Maturitas; 2011 Dec; 70(4):361-4. PubMed ID: 21958943
[TBL] [Abstract][Full Text] [Related]
3. First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055.
Raus K; Brucker C; Gorkow C; Wuttke W
Menopause; 2006; 13(4):678-91. PubMed ID: 16837890
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms.
Osmers R; Friede M; Liske E; Schnitker J; Freudenstein J; Henneicke-von Zepelin HH
Obstet Gynecol; 2005 May; 105(5 Pt 1):1074-83. PubMed ID: 15863547
[TBL] [Abstract][Full Text] [Related]
5. Black cohosh with or without St. John's wort for symptom-specific climacteric treatment--results of a large-scale, controlled, observational study.
Briese V; Stammwitz U; Friede M; Henneicke-von Zepelin HH
Maturitas; 2007 Aug; 57(4):405-14. PubMed ID: 17590291
[TBL] [Abstract][Full Text] [Related]
6. Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women.
Hofling M; Hirschberg AL; Skoog L; Tani E; Hägerström T; von Schoultz B
Menopause; 2007; 14(2):183-90. PubMed ID: 17108847
[TBL] [Abstract][Full Text] [Related]
7. Long-term endometrial and breast safety of a specific, standardized soy extract.
Palacios S; Pornel B; Vázquez F; Aubert L; Chantre P; Marès P
Climacteric; 2010 Aug; 13(4):368-75. PubMed ID: 20380569
[TBL] [Abstract][Full Text] [Related]
8. Menopause: a standardized isopropanolic black cohosh extract (remifemin) is found to be safe and effective for menopausal symptoms.
Ross SM
Holist Nurs Pract; 2012; 26(1):58-61. PubMed ID: 22157510
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of remifemin compared to tibolone for controlling of perimenopausal symptoms].
Bai WP; Wang SY; Liu JL; Geng L; Hu LN; Zhang ZL; Chen SL; Zheng SR
Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):597-600. PubMed ID: 20003788
[TBL] [Abstract][Full Text] [Related]
10. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
[TBL] [Abstract][Full Text] [Related]
11. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints - a prospective observational study.
Rostock M; Fischer J; Mumm A; Stammwitz U; Saller R; Bartsch HH
Gynecol Endocrinol; 2011 Oct; 27(10):844-8. PubMed ID: 21231853
[TBL] [Abstract][Full Text] [Related]
12. Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study.
Lundström E; Söderqvist G; Svane G; Azavedo E; Olovsson M; Skoog L; von Schoultz E; von Schoultz B
Fertil Steril; 2006 Apr; 85(4):989-95. PubMed ID: 16580385
[TBL] [Abstract][Full Text] [Related]
13. Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer.
Khan QJ; Kimler BF; O'Dea AP; Zalles CM; Sharma P; Fabian CJ
Breast Cancer Res; 2007; 9(3):R35. PubMed ID: 17537236
[TBL] [Abstract][Full Text] [Related]
14. Breast epithelial proliferation in postmenopausal women evaluated through fine-needle-aspiration cytology.
Conner P; Skoog L; Söderqvist G
Climacteric; 2001 Mar; 4(1):7-12. PubMed ID: 11379380
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of raloxifene in post-menopausal females.
Abdullah KN; Raoof A; Raoof M
J Coll Physicians Surg Pak; 2005 May; 15(5):266-9. PubMed ID: 15907234
[TBL] [Abstract][Full Text] [Related]
16. Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.
Fabian CJ; Kimler BF; Zalles CM; Khan QJ; Mayo MS; Phillips TA; Simonsen M; Metheny T; Petroff BK
Breast Cancer Res Treat; 2007 Nov; 106(1):75-84. PubMed ID: 17221152
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized, double-blind, and placebo-controlled study.
Nahas EA; Nahas-Neto J; Orsatti FL; Carvalho EP; Oliveira ML; Dias R
Maturitas; 2007 Nov; 58(3):249-58. PubMed ID: 17913408
[TBL] [Abstract][Full Text] [Related]
18. Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women.
Grady D; Vittinghoff E; Lin F; Hanes V; Ensrud K; Habel LA; Wallace R; Macer J; Cummings SR; Shepherd J
Menopause; 2007; 14(3 Pt 1):391-6. PubMed ID: 17224859
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method.
Eilertsen AL; Karssemeijer N; Skaane P; Qvigstad E; Sandset PM
BJOG; 2008 May; 115(6):773-9. PubMed ID: 18355366
[TBL] [Abstract][Full Text] [Related]
20. The effect of mifepristone on breast cell proliferation in premenopausal women evaluated through fine needle aspiration cytology.
Engman M; Skoog L; Söderqvist G; Gemzell-Danielsson K
Hum Reprod; 2008 Sep; 23(9):2072-9. PubMed ID: 18579510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
